Astria Therapeutics, a renowned biopharmaceutical company, has recently unveiled groundbreaking preclinical data in the esteemed Journal of Pharmacology and Experimental ...
Barclays PLC, a global financial services company, has recently acquired a stake in Astria Therapeutics, Inc. according to the firm's ...
Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company specializing in the development of therapeutics for rare and niche allergic and immunological ...
Astria Therapeutics, Inc: Engaging in Revolutionary Discoveries and Advancements in Biopharmaceuticals August 10, 2023 In recent developments, renowned financial services ...
On August 8, 2023, Wedbush analyst Laura Chico expressed her positive outlook for Astria Therapeutics (NASDAQ:ATXS) by maintaining an Outperform ...
Astria Therapeutics - A Promising Opportunity for Investors NASDAQ:ATXS opened with a bullish outlook at $12.50 on Monday, much to ...